News Update on merger EC offered remedy proposal Staff November 20, 2023 Read the full announcement in PDF Attachment Update on merger EC offered remedy proposal Iframe sync Post navigation Previous: Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASHNext: Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission. More Stories Diagnostics EHR Healthcare News Pharmaceutical Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope Staff January 11, 2026 Clinical Trial DNA News Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response Staff January 11, 2026 Cancer Clinical Trial Healthcare News Pharmaceutical Pregnancy Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand Staff January 11, 2026
